151 related articles for article (PubMed ID: 2450153)
1. Use of synthetic peptides to map antigenic sites of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Abens J; Undén A; Bartfai T
J Infect Dis; 1988 Apr; 157(4):738-42. PubMed ID: 2450153
[TBL] [Abstract][Full Text] [Related]
2. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of linear epitopes of pertussis toxin using overlapping synthetic decapeptides: identification of a human B-cell determinant in the S1 subunit indicative of acute infections.
Raupach B; Schmidt MA
Microb Pathog; 1994 Oct; 17(4):213-26. PubMed ID: 7536288
[TBL] [Abstract][Full Text] [Related]
4. Protective immunogenicity of two synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1347-51. PubMed ID: 2304902
[TBL] [Abstract][Full Text] [Related]
5. Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map.
De Magistris MT; Romano M; Bartoloni A; Rappuoli R; Tagliabue A
J Exp Med; 1989 May; 169(5):1519-32. PubMed ID: 2469760
[TBL] [Abstract][Full Text] [Related]
6. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
[TBL] [Abstract][Full Text] [Related]
7. Multiple T and B cell epitopes in the S1 subunit ("A"-monomer) of the pertussis toxin molecule.
Oksenberg JR; Ko C; Judd AK; Lim M; Kent A; Schoolnik GK; Steinman L
J Immunol; 1989 Dec; 143(12):4227-31. PubMed ID: 2480389
[TBL] [Abstract][Full Text] [Related]
8. Identification of linear B epitopes of pertactin of Bordetella pertussis induced by immunization with whole and acellular vaccine.
da Silva FR; Napoleão-Pego P; De-Simone SG
Vaccine; 2014 Oct; 32(47):6251-8. PubMed ID: 25252193
[TBL] [Abstract][Full Text] [Related]
9. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
[TBL] [Abstract][Full Text] [Related]
10. Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides.
Chong P; Zobrist G; Sia C; Loosmore S; Klein M
Infect Immun; 1992 Nov; 60(11):4640-7. PubMed ID: 1383153
[TBL] [Abstract][Full Text] [Related]
11. MHC-restricted recognition of immunogenic T cell epitopes of pertussis toxin reveals determinants in man distinct from the ADP-ribosylase active site.
Oksenberg JR; Judd AK; Ko C; Lim M; Fernandez R; Schoolnik GK; Steinman L
J Exp Med; 1988 Nov; 168(5):1855-64. PubMed ID: 2460578
[TBL] [Abstract][Full Text] [Related]
12. Antigenic heterogeneity in subunit S1 of pertussis toxin.
Perera VY; Wardlaw AC; Freer JH
J Gen Microbiol; 1986 Feb; 132(2):553-6. PubMed ID: 2872269
[TBL] [Abstract][Full Text] [Related]
13. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
Calver GA
Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203
[TBL] [Abstract][Full Text] [Related]
14. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates.
Gzyl A; Augustynowicz E; Gniadek G; Rabczenko D; Dulny G; Slusarczyk J
Vaccine; 2004 Jun; 22(17-18):2122-8. PubMed ID: 15149768
[TBL] [Abstract][Full Text] [Related]
15. Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies.
Kim KJ; Burnette WN; Sublett RD; Manclark CR; Kenimer JG
Infect Immun; 1989 Mar; 57(3):944-50. PubMed ID: 2465274
[TBL] [Abstract][Full Text] [Related]
16. Mapping of linear B-cell epitopes of the S2 subunit of pertussis toxin.
Schmidt W; Schmidt MA
Infect Immun; 1989 Feb; 57(2):438-45. PubMed ID: 2463969
[TBL] [Abstract][Full Text] [Related]
17. Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen.
Hijnen M; Mooi FR; van Gageldonk PG; Hoogerhout P; King AJ; Berbers GA
Infect Immun; 2004 Jul; 72(7):3716-23. PubMed ID: 15213111
[TBL] [Abstract][Full Text] [Related]
18. Determination of T cell epitopes on the S1 subunit of pertussis toxin.
Kim KJ; McKinness S; Manclark CR
J Immunol; 1990 May; 144(9):3529-34. PubMed ID: 1691761
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of whole-cell and acellular pertussis vaccines effectiveness in clearance of experimental B. pertussis infection in mice].
Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J
Med Dosw Mikrobiol; 2007; 59(2):123-35. PubMed ID: 17929410
[TBL] [Abstract][Full Text] [Related]
20. Epitope specificity of three anti-pertussis toxin monoclonal antibodies with dissimilar effects in assays of toxin neutralizing activity.
Halperin SA; Issekutz TB; Kasina A
Mol Immunol; 1991 Mar; 28(3):247-50. PubMed ID: 1708105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
